DNAAF8
Dynein axonemal assembly factor 8
Also known as: C16orf71, DAAF8_HUMAN, DKFZp686H2240, FLJ43261
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IYS4
- Gene
- DNAAF8
- Ensembl
- ENSG00000166246
- Chromosome
- 16
- Canonical length
- 520 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable dynein complex binding activity. Predicted to be involved in outer dynein arm assembly. Located in dynein axonemal particle. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
520 residues, UniProt reviewed canonical sequence.
>Q8IYS4|DNAAF8
1 MASNDKGMAP SLGSPWASQM GPWDAILKAV KDQLPSLDSD SPLSDYGEEE LFIFQRNQTS
61 LIPDLSEELA EDPADGDKSR AWVAAAEESL PEPVLVPAEL ATEPGCRQNT RTKDASSQEG
121 RDPGRPFESS GEVSALLGMA EEPPRWLEGD LGSLSFNTKG SQGPPWDPQA EATLSCHEGD
181 PKAEPLSTAS QESVNRRALR QERRKMIETD ILQKVTRDAC GPTSSDKGGV KEAPCHAAES
241 APRSKMPLVE PPEGPPVLSL QQLEAWDLDD ILQSLAGQED NQGNRAPGTV WWAADHRQVQ
301 DRMVPSAHNR LMEQLALLCT TQSKASACAR KVPADTPQDT KEADSGSRCA SRKQGSQAGP
361 GPQLAQGMRL NAESPTIFID LRQMELPDHL SPESSSHSSS DSEEEEEEEM AALGDAEGAS
421 PSSLGLRTCT GKSQLLQQLR AFQKGTAQPE LPASKGPAGG RAQAPEDTAG SRTGRKQHMK
481 LCAKGQSAQA RLPRGRPRAL GDVPEPGAAR EALMPPLEQLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DNAAF8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 74 nTPM
Expression across tissuesHPA
Tissue
- testis: 74 nTPM
- fallopian tube: 21 nTPM
- choroid plexus: 11 nTPM
- pituitary gland: 3.9 nTPM
- hypothalamus: 2.7 nTPM
- lung: 2.7 nTPM
Single-cell type
- late primary spermatocytes: 242 nCPM
- late spermatids: 99 nCPM
- respiratory ciliated cells: 68 nCPM
- fallopian tube ciliated cells: 50 nCPM
- early primary spermatocytes: 45 nCPM
- ependymal cells: 39 nCPM
Immune cell
- plasmacytoid DC: 1.1 nTPM
- naive B-cell: 0.4 nTPM
- non-classical monocyte: 0.3 nTPM
- classical monocyte: 0.2 nTPM
- myeloid DC: 0.2 nTPM
- memory CD4 T-cell: 0.1 nTPM
Brain region
- choroid plexus: 22 nTPM
- midbrain: 15 nTPM
- medulla oblongata: 13 nTPM
- spinal cord: 9.5 nTPM
- pons: 7.2 nTPM
- cerebellum: 7.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.52
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dynein axonemal assembly factor 8
- Dynein axonemal-associated protein 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DNAAF8 as an antibody target. Whether an autoantibody or antibody against DNAAF8 could matter depends on whether native DNAAF8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DNAAF8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DNAAF8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...